ImmPACT Bio USA Inc. (Series A)
Funding Details
Awarder
Inbox
Date Award
August 20, 2020
Vertical
Cell Therapy
Funding URL
View Funding Page
Funding Amount
$18,000,000
Company Info
Founding Year
2017
Founders
Prof. Gideon Gross
Market
Solid Tumors
Location
Camarillo, CA, USA
Coinvestors
Bukwang Pharmaceutical, Hayan Health Networks, Johnson & Johnson Development Corporation (JJDC), JVC Investment Partners, Novartis, OrbiMed Advisors, RM Global Partners, Takeda Ventures
Company Description

ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The company was founded based on the research of Prof. Gideon Gross of the Migal Research Institute and has been incubated in the FutuRx incubator since 2017.

Links
Website
Back to HomeBack to Cell Therapy DealsView Funding Announcement